NextCure Inc.

NASDAQ: NXTC · Real-Time Price · USD
5.17
0.02 (0.43%)
At close: Aug 15, 2025, 3:47 PM
5.09
-1.64%
After-hours: Aug 15, 2025, 04:04 PM EDT

NextCure Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
2.87M 3.68M 4.48M 4.3M
Gross Profit
-2.87M -3.68M -4.48M -4.3M
Operating Income
-59.75M -67.64M -75.91M -70.77M
Interest Income
n/a n/a 1.17M 1.32K
Pretax Income
-55.65M -62.72M -74.73M -69.39M
Net Income
-55.65M -62.72M -69.43M -69.39M
Selling & General & Admin
15.72M 19.71M 21.71M 20.57M
Research & Development
41.49M 47.93M 54.2M 50.19M
Other Expenses
2.54M n/a n/a n/a
Operating Expenses
59.75M 67.64M 75.91M 70.77M
Interest Expense
n/a n/a n/a 77K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
59.75M 67.64M 75.91M 70.77M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
2.33M 2.32M 2.31M 2.3M
Shares Outstanding (Diluted)
2.33M 2.32M 2.31M 2.3M
EPS (Basic)
-23.88 -27.04 -32.32 -30.15
EPS (Diluted)
-23.88 -27.04 -32.32 -30.15
EBITDA
-54.34M -59.04M -70.25M -65.01M
EBIT
-57.21M -62.72M -74.73M -69.31M
Depreciation & Amortization
2.87M 3.68M 4.48M 4.3M